Skip to main content

Liquidia Corp

LQDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001819576

In the last 90 days, Liquidia Corp insiders filed 0 open-market purchases and 15 sales; 306 institutions reported holding it in 13F filings for Q3 2026, worth $2.30B in total; no superinvestor holds it.

Holders of 5% or more of LQDA

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Liquidia Corp, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of LQDA
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A11.90%10.6M shares–Oct 18, 20243 filingsJul 8, 2026SEC
Farallon Capital Partners, L.P.13G/A9.90%8.66M shares−0.05 ppfrom 9.95%Jul 11, 20253 filingsFeb 9, 2026SEC
Farallon Capital Management, L.L.C.13G/A9.40%8.37M shares–Aug 4, 20261 filingAug 4, 2026SEC
Manning Paul B13G/A6.50%4.95M shares–Feb 16, 20216 filingsAug 14, 2026SEC
Iszo Capital LP13G5.20%4.71M sharesNewNov 19, 20261 filingNov 19, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

32 Schedule 13D and 13G filings on Liquidia Corp, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on LQDA
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 19, 20263:56 PM ETIszo Capital LPand 3 others13G5.20%4.71M sharesNewNov 12, 2026SEC
Aug 14, 20267:39 PM ETManning Paul Band 2 others13G/A6.50%4.95M shares–Jun 30, 2026SEC
Aug 4, 20268:32 AM ETFarallon Capital Management, L.L.C.and 28 others13G/A9.40%8.37M shares–Jun 30, 2026SEC
Jul 8, 202611:12 AM ETBlackRock, Inc.13G/A11.90%10.6M shares–Jun 30, 2026SEC
Feb 9, 20268:56 AM ETFarallon Capital Partners, L.P.and 30 others13G/A9.90%8.66M shares−0.05 ppfrom 9.95%Dec 31, 2025SEC
Nov 12, 202512:15 PM ETFarallon Capital Partners, L.P.and 29 others13G/A9.95%8.57M shares+1.95 ppfrom 8.00%Sep 30, 2025SEC
Jul 11, 20256:32 PM ETFarallon Capital Partners, L.P.and 29 others13G8.00%6.83M sharesNewJul 7, 2025SEC
Feb 12, 20255:34 PM ETLegend Aggregator, LPand 1 other13G/A2.20%1.86M shares–Below 5%Dec 31, 2024SEC
Nov 12, 2024Manning Paul B13G/AOld format–––SEC
Nov 8, 2024BlackRock, Inc.13GOld format–––SEC
Oct 18, 2024BlackRock, Inc.13GOld format–New–SEC
Sep 12, 2024Caligan Partners LP13D/AOld format–––SEC
Sep 4, 2024Caligan Partners LP13D/AOld format–––SEC
Feb 14, 2024Manning Paul B13G/AOld format–––SEC
Feb 7, 20245:09 PM ETBlackRock Inc.13G/AOld format–––SEC
Jan 31, 20242:08 PM ETBlackRock Inc.13GOld format–––SEC
Jan 16, 2024Legend Aggregator, LP13GOld format–New–SEC
Dec 14, 2023Caligan Partners LP13D/AOld format–––SEC
May 5, 202311:52 AM ETBlackRock Inc.13GOld format–––SEC
Feb 14, 2023Manning Paul B13G/AOld format–––SEC
Feb 13, 20239:25 AM ETBlackRock Inc.13GOld format–New–SEC
Feb 1, 2023Canaan VIII LP13G/AOld format–––SEC
Feb 14, 2022Manning Paul B13G/AOld format–––SEC
Jan 5, 2022New Enterprise Associates 12, Limited Partnership13D/AOld format–––SEC
Dec 7, 2021Caligan Partners LP13D/AOld format–––SEC
Apr 15, 2021Caligan Partners LP13DOld format–New–SEC
Feb 16, 2021Manning Paul B13GOld format–New–SEC
Feb 11, 2021Xeraya LT Ltd13G/AOld format–––SEC
Feb 5, 2021Eshelman Ventures, LLC13G/AOld format–––SEC
Feb 3, 2021Canaan VIII LP13G/AOld format–––SEC
Jan 28, 2021Eshelman Ventures, LLC13G/AOld format–––SEC
Jan 22, 2021Eshelman Ventures, LLC13G/AOld format–––SEC

Form 144: proposed insider sales

45 notices from officers, directors and other affiliates planning to sell Liquidia Corp shares, newest first.

Form 144 notices for LQDA
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Sep 14, 20264:11 PM ETRamandeep SinghDirector8.47K$560.2KSep 14, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Sep 11, 20265:17 PM ETRamandeep SinghDirector9.02K$619.2KSep 11, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Aug 21, 20264:37 PM ETJason AdairOfficer73.6K$5.23MAug 21, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Aug 19, 20264:26 PM ETKatherine T. Rielly-GauvinDirector55.2K$4.10MAug 19, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Aug 19, 20264:04 PM ETRajeev SaggarOfficer50.0K$3.70MAug 19, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Aug 17, 20265:01 PM ETRajeev SaggarOfficer29.5K$2.27MAug 17, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jun 11, 20264:26 PM ETSarah KreppOfficer24.9K$1.62MJun 11, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jun 10, 20264:52 PM ETCanaan VIII LPDirector200.0K$13.0MJun 10, 2026UBS Financial Services IncSEC
Jun 8, 20264:11 PM ETCanaan VIII LPDirector200.0K$12.8MJun 8, 2026UBS Financial Services IncSEC
Jun 4, 20266:38 PM ETPaul B ManningDirector200.0K$11.1MJun 4, 2026Fidelity Brokerage Services LLCSEC
Jun 4, 20265:24 PM ETCanaan VIII LPDirector200.0K$13.0MJun 4, 2026UBS Financial Services IncSEC
Jun 1, 20269:56 AM ETKirsch Arthur SDirector30.0K$1.84MJun 1, 2026Fidelity Brokerage Services LLCSEC
May 21, 20265:12 PM ETRamandeep SinghDirector29.5K$1.77MMay 21, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
May 20, 20264:37 PM ETSerendipity Biopharma LLCDirector · Officer106.4K$6.38MMay 20, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
May 14, 20264:26 PM ETSerendipity Biopharma LLCDirector · Officer100.0K$5.76MMay 14, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
May 11, 20265:52 PM ETCanaan VIII LPDirector318.9K$15.9MMay 11, 2026UBS Financial Services IncSEC
May 8, 20264:19 PM ETSerendipity Biopharma LLCDirector · Officer100.0K$4.23MMay 8, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
May 7, 20264:18 PM ETSerendipity Biopharma LLCDirector · Officer25.0K$1.05MMay 7, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Apr 17, 20264:39 PM ETSerendipity Biopharma LLCDirector · Officer68.8K$2.85MApr 17, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Apr 16, 20264:13 PM ETSerendipity Biopharma LLCDirector · Officer25.0K$1.00MApr 16, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Apr 15, 20264:43 PM ETSerendipity Biopharma LLCDirector · Officer24.7K$957.4KApr 15, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Apr 15, 20264:42 PM ETMichael KasetaOfficer139.4K$5.40MApr 15, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Apr 14, 20264:37 PM ETMichael KasetaOfficer3.00K$116.5KApr 14, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Apr 10, 20264:35 PM ETSerendipity Biopharma LLCDirector · Officer25.0K$1.01MApr 10, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Apr 10, 20264:34 PM ETMichael KasetaOfficer23.8K$960.5KApr 10, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC

Showing the latest 25. See the LQDA notices from the last 12 months